Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor.
about
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsLysophosphatidic acid production and action: critical new players in breast cancer initiation and progressionLipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assayLipid phosphate phosphatase (LPP3) and vascular developmentInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Lysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrestPharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsRho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid2D binary QSAR modeling of LPA3 receptor antagonism.Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cellsLPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1β releaseTargeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.ATX-LPA receptor axis in inflammation and cancer.Novel lysophosphoplipid receptors: their structure and function.Aiming drug discovery at lysophosphatidic acid targets.G-protein-coupled receptor cell signaling pathways mediating embryonic chick retinal growth cone collapse induced by lysophosphatidic acid and sphingosine-1-phosphateGPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaquesUnique uterine localization and regulation may differentiate LPA3 from other lysophospholipid receptors for its role in embryo implantation.TNF-alpha promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines.The impact of bioactive lipids on cardiovascular development.Renal intercalated cells sense and mediate inflammation via the P2Y14 receptor.(S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activityLysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions.Is GPR17 a P2Y/leukotriene receptor? examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17.Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs.Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cellsP2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion.Intercellular Lipid Mediators and GPCR Drug DiscoveryGenome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells.Roles of LPA in ovarian cancer development and progression.Dissecting the role of the S1P/S1PR axis in health and disease.Neuron-astroglial interactions in cell-fate commitment and maturation in the central nervous system.Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.Convergent regulation of neuronal differentiation and Erk and Akt kinases in human neural progenitor cells by lysophosphatidic acid, sphingosine 1-phosphate, and LIF: specific roles for the LPA1 receptorEGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrolSilencing of P2Y2 receptor delays Ap4A-corneal re-epithelialization process.
P2860
Q24605072-98166FAC-F8E1-4E70-8038-5DE6D5847302Q24616764-8C47591C-C4BB-4203-B511-905A7CA679A8Q24654730-7DB7165A-4970-4056-A5DF-C95CA7084B59Q27002640-08D7ECC9-D727-4962-B25F-3651010866D1Q28298445-C03EA20F-1F1A-4BC1-87D8-3595DB37C4E0Q28478339-3A7FD7AC-F25D-4155-AA06-8E46E180041CQ30410634-B2B4AB6D-EA30-40CD-AA91-320CB9185D5CQ30429523-FD2BF466-BD4B-4FE8-92A8-4F98EEB44F01Q30486707-F3884C92-6EB8-45A3-A570-B215C8ADE95DQ30538666-8D63603B-5357-4370-A7C7-80C64F2C10D8Q33548210-64489EF0-0E86-4367-9381-EC499C6F6C0FQ33636488-AF96665A-F140-4128-A630-EC2A93D45BB7Q33809139-6C982839-4E61-492B-93B6-713F28417722Q33862583-851F3449-2729-44E0-9C24-7A27B040F449Q33955207-3107B3FA-CDD2-4EBA-B24E-94A9EC193B2EQ34199719-1F42B5CA-B4EA-4C35-9337-6FFB6C53D02FQ34238610-5500E4EF-E5BD-4965-B0AF-19CE612824BFQ34339759-F385BF5F-542B-410D-92F7-CCD9A4A6F673Q34475580-D72A70C5-76A6-4FCA-8EDE-ED22DAFC0633Q34682812-CF29778D-8654-4936-8597-332F47B9EDC0Q34887469-A1702396-B2F8-4D54-BAF0-44F878BEB865Q35036338-1F89C164-19BA-473C-89A7-9C36661A1E0DQ35173287-398A8B48-A4BA-4F36-9FAA-EA8F2188E455Q35208204-8D8BF84E-2A24-4B82-93D0-D9C90CBC2B64Q36246895-A7389FE1-04D4-45B9-8AA5-9CF62D3988BCQ36330107-48BE72B0-83B4-4797-8E2F-BADEC192B579Q36412800-4DEF65DC-A6E7-49DE-8376-8E87BD5980A3Q37193227-6159ABB6-D0E2-4441-ABDB-07F03F6B43CEQ37250907-5B3CB120-658A-4D8D-A9DE-8A8CD967E3BAQ37289059-D50B2F55-A4A7-4B37-B056-8B5A540E759BQ37391849-DA57970C-7942-4CA7-A09C-05A3C20C8A42Q37429742-48B5D0C4-51C7-40AA-B98D-903534B7BFE2Q37462198-5A96F74C-BDB0-4DC5-A908-7B2F3AC41D4AQ37650618-10593FA9-3224-4427-B5C1-E189DD631E22Q37830235-D91E82FF-FF7B-4B1F-BF8F-612329586143Q38012043-A0BF992F-46E3-44D5-A09B-FF435EF9507AQ38660494-F2804F52-3130-44EC-941E-0F26E79C448AQ38937797-49EEA77F-7959-4AA5-8CF9-BB13E978E58EQ39249383-31483107-4888-4D43-AFC2-3B2B5174BA92Q39838997-BAB93FB4-9C40-4707-BB10-40F28EC24E20
P2860
Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Identification of the orphan G ...... ysophosphatidic acid receptor.
@en
Identification of the orphan G ...... ysophosphatidic acid receptor.
@nl
type
label
Identification of the orphan G ...... ysophosphatidic acid receptor.
@en
Identification of the orphan G ...... ysophosphatidic acid receptor.
@nl
prefLabel
Identification of the orphan G ...... ysophosphatidic acid receptor.
@en
Identification of the orphan G ...... ysophosphatidic acid receptor.
@nl
P2093
P1476
Identification of the orphan G ...... lysophosphatidic acid receptor
@en
P2093
Kenichi Tabata
Masanori Murakami
Norihisa Fujita
P304
P356
10.1016/J.BBRC.2008.04.145
P407
P577
2008-05-06T00:00:00Z